AEGiS-SC: OPINION: An end to AIDS? San Francisco ChronicleImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


OPINION: An end to AIDS?

San Francisco Chronicle - August 20, 2008


First it was a mystery, then a peril and a political football, and now it's a research marathon. Nearly three decades on, AIDS has collected all these labels.

It may be a long wait for the next name change. Will there be a breakthrough cure or vaccine? A treatment drug that will prove cheap and easy to dispense, or a prevention plan that will cut down on the 2 million infected last year with HIV, which causes AIDS?

The epidemic, which has killed 25 million and infected another 33 million, is at a frustrating yet tantalizing turning point, as evidenced at a worldwide conference that drew 20,000 scientists and health care experts to a Mexico City conference this month.

The yearly infection rate has curved down from a peak of 2.2 million in 2005 and life-prolonging drugs sustain 3 million, the largest number ever. Also, the United States has approved a five-year plan to spend $40 billion in the fight, by far the biggest expenditure by any nation.

But slow and steady isn't good enough. As infection rates drop, so has the sense of urgency. Former President Bill Clinton, who has championed AIDS research in his elder-statesman years, spoke at the Mexico City gathering, but no other big-country leader showed up. No medical breakthroughs premiered. Protests were absent in hallways dotted with drug company trade-show displays. The public attention surrounding AIDS has faded.

There are doubts along the frontlines in the battle as well. AIDS is vacuuming up scarce medical money in poor countries, critics say. Also, life-sustaining drug regimens, such as those paid for by the giant U.S. aid program, amount to a costly future obligation. On a broader scale, will it ever be possible for national leaders to focus on a topic that touches so many hot-button topics: prostitution, drug use, women's rights and civil liberty protections for HIV-infected people?

But these could be momentary quandaries if something good emerges from the world's research labs. In the 1980s, scientists predicted a cure within years, a failed boast that few scientists will go near today. Another home-run answer - a preventive vaccine - remains a distant hope, given the lengthy list of failed attempts.

Instead there are small-scale innovations to try, such as circumcision for men, microbicides for women and prevention plans using condoms, counseling and abstinence. All of these ideas come loaded with controversies, setbacks and doubts, but they need tryouts in a landscape with no solid answers.

It's worth remembering how hopeless the AIDS scourge once seemed. There were demonstrations outside drug firms and government offices to demand attention and medical help. Big-city newspapers ran lists of obituaries of single young men. Washington rushed to bar foreigners who tested positive for the virus, a policy finally repealed this month.

AIDS remains lethal and unsolved. That should be reason enough to fight it. But the world should be encouraged by small steps that are paying off - and take even more of them.


080820
SC080805


Copyright © 2008 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .